Lumida
/MXCT
⌘K
MaxCyte Inc

MaxCyte Inc

MXCT
$1.24USD-8.15%-0.11 today

MARKET CAP

132.8M

P/E (TTM)

FWD P/E

DAY RANGE

$1 – $1

52W RANGE

$1
$2

AI Summary

Stalk
Buy NowMedium

MXCT remains in a Stage 2 advance, evidenced by higher highs and higher lows over the past quarter, but the active Blow-Off Top pattern signals a terminal phase and elevated transition risk. Price is currently pulling back into the rising 9/21 EMA zone, offering a favorable execution point, with short-term indicators in neutral territory and no clear exhaustion. Medium-term structure remains bullish as long as intermediate support holds, although the long-term downtrend suggests caution. Overall, conditions align for tactical participation on the long side now.

  • $147.7 M cash and no debt provides strategic investment flexibility
  • SPL program-related revenue up 62% YoY to $3.4 M on clinical milestones
  • Q1 total revenue declined 7% YoY to $9.7 M, missing growth targets
Full analysis →
Insider Trades13 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Mar 17, 2026SellMXCTDouglas J SwirskyCHIEF FINANCIAL OFFICER10,142$0.81$132.8M-47.68%+92.73%$8.3K-6.27%Buy Now
Aug 13, 2025BuyMXCTDouglas J SwirskyCHIEF FINANCIAL OFFICER50,000$1.29$132.8M-47.68%+92.73%$64.5K+44.72%Buy Now
Aug 13, 2025BuyMXCTMaher MasoudPresident and CEO75,000$1.37$132.8M-47.68%+92.73%$102.9K+75.00%Buy Now
Mar 18, 2025SellMXCTDavid I. SandovalGENERAL COUNSEL353$3.18$132.8M-47.68%+92.73%$1.1K-0.55%Buy Now
Mar 18, 2025SellMXCTAli SoleymannezhadChief Commercial Officer1,211$3.18$132.8M-47.68%+92.73%$3.9K-2.00%Buy Now
Mar 18, 2025SellMXCTDouglas J SwirskyCHIEF FINANCIAL OFFICER6,939$3.18$132.8M-47.68%+92.73%$22.1K-5.84%Buy Now
Jan 13, 2025SellMXCTDavid I. SandovalGENERAL COUNSEL4,466$4.54$132.8M-47.68%+92.73%$20.3K-9.73%Buy Now
Aug 1, 2024SellMXCTThomas M. RossEVP, GLOBAL SALES66,666$3.04$132.8M-47.68%+92.73%$202.8K+0.00%10b5-1Buy Now
Jul 8, 2024SellMXCTThomas M. RossEVP, GLOBAL SALES66,666$2.84$132.8M-47.68%+92.73%$189.1K+0.00%10b5-1Buy Now
Jun 20, 2024SellMXCTThomas M. RossEVP, GLOBAL SALES66,666$2.87$132.8M-47.68%+92.73%$191.2K+0.00%10b5-1Buy Now
Jun 7, 2024BuyMXCTMaher MasoudPresident and CEO100,000$4.89$132.8M-47.68%+92.73%$489.1K+338.33%Buy Now
Dec 4, 2023SellMXCTDouglas DoerflerPresident and CEO248,900$2.59$132.8M-47.68%+92.73%$644.4K+0.00%10b5-1Buy Now
Nov 29, 2023SellMXCTDouglas DoerflerPresident and CEO51,100$2.52$132.8M-47.68%+92.73%$128.8K+0.00%10b5-1Buy Now